A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of ABS-1230 in Pediatric and Young Adult Participants With KCNT1-related Epilepsy
for KCNT1-Related Epilepsy
1 location in Hackensack
Sponsor: Actio Biosciences, Inc.
Sex: All·Age: 1 Month - 21
Code: NCT07600736·Phase 2·Recruiting·Listed May 2026